EP3924367A4 - Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis - Google Patents

Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis Download PDF

Info

Publication number
EP3924367A4
EP3924367A4 EP20908461.5A EP20908461A EP3924367A4 EP 3924367 A4 EP3924367 A4 EP 3924367A4 EP 20908461 A EP20908461 A EP 20908461A EP 3924367 A4 EP3924367 A4 EP 3924367A4
Authority
EP
European Patent Office
Prior art keywords
vegf
growth factor
wound healing
vascular endothelial
endothelial growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20908461.5A
Other languages
German (de)
French (fr)
Other versions
EP3924367A2 (en
Inventor
Anoop Kumar Thekkuveettil
Sheeja Liza EASO
Geethu SHAJI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sree Chitra Tirunal Institute For Medical Sciences And Technology
Original Assignee
Sree Chitra Tirunal Institute For Medical Sciences And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sree Chitra Tirunal Institute For Medical Sciences And Technology filed Critical Sree Chitra Tirunal Institute For Medical Sciences And Technology
Publication of EP3924367A2 publication Critical patent/EP3924367A2/en
Publication of EP3924367A4 publication Critical patent/EP3924367A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
EP20908461.5A 2019-04-04 2020-04-02 Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis Withdrawn EP3924367A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201941013671 2019-04-04
PCT/IN2020/050321 WO2020202214A2 (en) 2019-04-04 2020-04-02 Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis

Publications (2)

Publication Number Publication Date
EP3924367A2 EP3924367A2 (en) 2021-12-22
EP3924367A4 true EP3924367A4 (en) 2022-10-12

Family

ID=72667624

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20908461.5A Withdrawn EP3924367A4 (en) 2019-04-04 2020-04-02 Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis

Country Status (2)

Country Link
EP (1) EP3924367A4 (en)
WO (1) WO2020202214A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928061B2 (en) * 1996-08-23 2011-04-19 Vegenics Pty Limited Methods of using VEGF-D polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7928061B2 (en) * 1996-08-23 2011-04-19 Vegenics Pty Limited Methods of using VEGF-D polypeptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ORLANDINI M ET AL: "IDENTIFICATION OF A C-FOS INDUCED GENE THAT IS RELATED TO THE PLATELET-DERIVED GROWTH FACTOR/VASCULAR ENDOTHELIAL GROWTH FACTOR FAMILY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, vol. 93, no. 21, 15 October 1996 (1996-10-15), pages 11675 - 11680, XP002029340, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.21.11675 *
RISSANEN TUOMAS T ET AL: "VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses", CIRCULATION RESEARCH, AMERICAN HEART ASSOCIATION, INC, US, vol. 92, no. 10, 30 May 2003 (2003-05-30), pages 1098 - 1106, XP002491555, ISSN: 1524-4571, DOI: 10.1161/01.RES.0000073584.46059.E3 *
VEIKKOLA TANJA ET AL: "VEGFs, receptors and angiogenesis", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, vol. 9, no. 3, 1 June 1999 (1999-06-01), pages 211 - 220, XP002198307, ISSN: 1044-579X, DOI: 10.1006/SCBI.1998.0091 *
YAMADA Y ET AL: "Molecular Cloning of a Novel Vascular Endothelial Growth Factor, VEGF-D", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 42, no. 3, 15 June 1997 (1997-06-15), pages 483 - 488, XP004459556, ISSN: 0888-7543, DOI: 10.1006/GENO.1997.4774 *

Also Published As

Publication number Publication date
WO2020202214A2 (en) 2020-10-08
WO2020202214A3 (en) 2020-12-03
WO2020202214A4 (en) 2021-03-11
EP3924367A2 (en) 2021-12-22

Similar Documents

Publication Publication Date Title
EP3908209A4 (en) Filamentary devices for treatment of vascular defects
EP3908354A4 (en) Filamentary devices for treatment of vascular defects
EP3723819A4 (en) Wound dressing
EP3846757A4 (en) Adaptable adhesive wound dressings
EP3424948A4 (en) Vascular endothelial growth factor targeting peptide-elastin fusion polypeptide and self-assembling nanostructure, which are for inhibiting angiogenesis
CA191072S (en) Wound dressing
EP3911253A4 (en) Vascular implant
EP3957576A4 (en) Film-packed tissue set package
EP4003334A4 (en) Yap inhibition for wound healing
GB201805447D0 (en) Wound healing
EP4062869A4 (en) Dual-layer lumen stent
GB201912071D0 (en) Wound dressing
EP4034007A4 (en) Balloon basket catheter device
EP4074311A4 (en) Composition for wound healing, containing metal-organic framework
EP3242677A4 (en) Therapeutic angiogenesis for wound healing
EP3924367A4 (en) Vascular endothelial growth factor (vegf) for better wound healing through enhanced angiogenesis
EP3906000A4 (en) Re-closable wound dressing
EP3988157A4 (en) Balloon catheter
PL3739149T3 (en) Automatic winder
EP3954348A4 (en) Improved wound dressing member
DK3838238T3 (en) DOUBLE COATING FOR WOUND DRESSINGS
EP3970782A4 (en) Balloon catheter
EP3991777A4 (en) Balloon catheter
GB201812812D0 (en) Disposable wound dressings
EP4048197A4 (en) Absorbable vascular filter

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210804

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220909

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/11 20060101ALI20220905BHEP

Ipc: A61K 39/00 20060101ALI20220905BHEP

Ipc: C07K 14/515 20060101AFI20220905BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230412